Zum Inhalt springen

NOF to Exhibit at ARVO 2026

NOF to Exhibit at ARVO 2026 from May 3 – May 6

Denver, CO, USA (May 3 - 7, 2026)

NOF CORPORATION is pleased to announce its participation in the upcoming ARVO 2026 (Association for Research in Vision and Ophthalmology) to be held at the Colorado Convention Center, Denver, CO, USA from May 3 to May 7.

The Conference web site: https://www.arvo.org/annual-me...

At the event, NOF CORPORATION will highlight its YT-LIPIDURE® series, a major product line for eye drops, at booth #5030 from May 3 to May 6.


YT-LIPIDURE® series

YT-LIPIDURE® series (MPC* polymer) provides the following functions in eye drops.
• Improvement of dry eye scores
• Protective effect against preservatives
• Prevention of tear film breakup
• Stabilization of the tear film
• Enhanced moisturization
• Compatibility with hard and soft contact lenses
• Approved as additives by PMDA** in Japan

*MPC:2-methacryloyloxyethylphosphorylcholine
**PMDA:Pharmaceuticals and Medical Devices Agency


For further information or to arrange a meeting, please refer to the contact information below.

[Americas]

NOF AMERICA CORPORATION

E-mail: info@nofamerica.com

Tel:

+1-914-681-9790 (New York Office)

+1-650-993-7375 (San Francisco Office)

+1-914-704-7903 (Boston Office)

[Europe]

NOF EUROPE GmbH

E-mail: info-eu@nofeurope.com

Tel: +49-69-7706-100-0

[Asia Pacific, Japan]

NOF CORPORATION

Life Science Division

E-mail: ddsinfo@nof.co.jp

Tel: +81-3-5424-6741

[China]

NOF (Shanghai) Co. Ltd.

Tel: +86-21-6210-1100